Finland
Onego Bio, founded in 2022, is a Finnish startup operating at the intersection of Biotechnology, Food and Beverage, and Manufacturing industries. The company is pioneering a novel approach to food production through its flagship product, Bioalbumen®. This non-animal egg protein is produced via precision fermentation and mirrors the amino acid structure of natural egg proteins.
The innovation promises a remarkable reduction in environmental impact—approximately 90% less than traditional egg production—without compromising on taste, nutrition, or functionality. Onego Bio positions itself as a solution for food manufacturers seeking to ensure cost and supply stability, given its product's versatility and consistency.
Recently, the company secured a $2.00M grant investment from Newtree Impact, underscoring investor confidence in creating a more resilient food system. As a young company, Onego Bio is poised for growth, leveraging its innovative edge in a rapidly evolving market.
